Question: why is nvcr stock dropping?
Answer: In response to the reported fourth-quarter and full-year results, shares of NovoCure (NASDAQ:NVCR), a high-growth medical device company that is focused on cancer, fell as much as 12% in early-morning trading on Thursday. The stock eventually recovered and was down about 2% as of 3:05 p.m. EST.